ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $579,390 | -7.1% | 93,000 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $624,000 | +5.4% | 93,000 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $592,000 | +37.0% | 93,000 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $432,000 | -7.3% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $466,000 | -95.0% | 93,000 | -74.1% | 0.00% | -90.0% |
| Q4 2020 | $9,328,000 | -30.1% | 358,800 | 0.0% | 0.04% | -52.4% |
| Q3 2020 | $13,336,000 | -2.5% | 358,800 | +34.6% | 0.08% | -27.6% |
| Q2 2020 | $13,680,000 | +158.2% | 266,600 | +123.3% | 0.12% | +314.3% |
| Q3 2018 | $5,298,000 | +13.2% | 119,400 | 0.0% | 0.03% | +27.3% |
| Q2 2018 | $4,680,000 | – | 119,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |